To: Elizabeth-Ashley Matthews, MPA
Director, Division of Health Care Delivery
Prevention and Population Health Group
Center for Medicare and Medicaid Innovation
"The DAA continues to believe the expansion of the Diabetes Prevention Program (DPP) to Medicare beneficiaries has the potential to completely transform the trajectory of type 2 diabetes. However, we also believe that in the course of expanding the model, CMS made what were well-intentioned modifications to the Medicare DPP pilot. With these modifications, the Model has not achieved the increased supplier and beneficiary participation envisioned at its launch."
Read the Full Summary 
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.
